IL50187A0 - Novel immunological adjuvants their production and compositions containing them - Google Patents

Novel immunological adjuvants their production and compositions containing them

Info

Publication number
IL50187A0
IL50187A0 IL50187A IL5018776A IL50187A0 IL 50187 A0 IL50187 A0 IL 50187A0 IL 50187 A IL50187 A IL 50187A IL 5018776 A IL5018776 A IL 5018776A IL 50187 A0 IL50187 A0 IL 50187A0
Authority
IL
Israel
Prior art keywords
production
compositions containing
immunological adjuvants
novel immunological
novel
Prior art date
Application number
IL50187A
Other languages
English (en)
Original Assignee
Anvar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anvar filed Critical Anvar
Publication of IL50187A0 publication Critical patent/IL50187A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/5555—Muramyl dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/32—Mycobacterium
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/27—Cyclic peptide or cyclic protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL50187A 1975-08-05 1976-08-02 Novel immunological adjuvants their production and compositions containing them IL50187A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7524440A FR2320107A1 (fr) 1975-08-05 1975-08-05 Nouveaux adjuvants immunologiques, procede pour leur obtention et compositions les contenant

Publications (1)

Publication Number Publication Date
IL50187A0 true IL50187A0 (en) 1976-10-31

Family

ID=9158793

Family Applications (1)

Application Number Title Priority Date Filing Date
IL50187A IL50187A0 (en) 1975-08-05 1976-08-02 Novel immunological adjuvants their production and compositions containing them

Country Status (11)

Country Link
US (1) US4110434A (enExample)
JP (1) JPS5234917A (enExample)
BE (1) BE844672A (enExample)
DE (1) DE2634904A1 (enExample)
DK (1) DK352276A (enExample)
FR (1) FR2320107A1 (enExample)
GB (1) GB1525763A (enExample)
IL (1) IL50187A0 (enExample)
LU (1) LU75522A1 (enExample)
NL (1) NL7608680A (enExample)
SE (1) SE7608640L (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU727647A1 (ru) * 1977-11-02 1980-04-15 Институт биоорганической химии им.М.М.Шемякина Гликопептиды,обладающие противоопухолевой активностью и способ их получени
US4397844A (en) * 1978-02-24 1983-08-09 Ciba-Geigy Corporation Antigen derivatives and processes for their preparation
US4313934A (en) * 1979-05-08 1982-02-02 Kirin Beer Kabushiki Kaisha Physiologically active polysaccharides, production and uses thereof
JPS59116681A (ja) * 1982-12-23 1984-07-05 セイコーインスツルメンツ株式会社 液晶表示装置
US4897256A (en) * 1986-11-25 1990-01-30 Abbott Laboratories LHRH analog formulations
ATE179333T1 (de) * 1993-01-29 1999-05-15 Vetrepharm Inc Immunotherapeutische zubereitung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL2816C (enExample) *
US3429868A (en) * 1956-03-12 1969-02-25 Kiyoshi Kominato Method of preparing a series of prosthetic groups and coenzymes of a new redox-enzyme which are present in plants,animals,or foods and have vitamin-like activity
NL7308450A (enExample) * 1972-06-20 1973-12-27
US3941762A (en) * 1973-05-07 1976-03-02 E. R. Squibb & Sons, Inc. O-acyl derivatives of antibiotic EM-49
FR2269961B1 (enExample) * 1974-05-06 1978-03-24 Anvar
US3992528A (en) * 1975-02-18 1976-11-16 Research Corporation Anti-viral substance containing peptide, fatty acid and carbohydrate moieties

Also Published As

Publication number Publication date
FR2320107B1 (enExample) 1980-01-11
GB1525763A (en) 1978-09-20
SE7608640L (sv) 1977-02-06
LU75522A1 (enExample) 1977-03-25
FR2320107A1 (fr) 1977-03-04
DK352276A (da) 1977-02-06
US4110434A (en) 1978-08-29
DE2634904A1 (de) 1977-02-10
JPS5234917A (en) 1977-03-17
BE844672A (fr) 1976-11-16
NL7608680A (nl) 1977-02-08

Similar Documents

Publication Publication Date Title
IL50836A0 (en) Novel cyclopolypeptides their production and pharmaceutical compositions containing them
GB1541435A (en) Immunological materials
IL50791A0 (en) Novel nutritional compositions
JPS52106877A (en) Novel pyridinecarboxyamides and their preparation
JPS5289662A (en) Novel polyhalogenoosteroid and preparation thereof
PT65688A (en) Novel 1-benzazolylalkyl-4-substituted-piperidines
JPS54119472A (en) Manufacture of novel dibenzopyrane intermediate
JPS51138626A (en) Novel compound and preparation thereof
JPS5253857A (en) Novel oxazolidinee22one compound and preparation thereof
JPS5251353A (en) Novel homologue of natural prostagladine
IL50522A0 (en) Novel n-aryl-n-(4-piperidinyl)-arylacetamides their preparation and pharmaceutical compositions containing them
JPS51115427A (en) Preparation of ethylbenzole
JPS51131836A (en) Preparation of acetoacetylarylamide
IL50187A0 (en) Novel immunological adjuvants their production and compositions containing them
GB1539733A (en) Preparation of 3-phenoxybenzaldehydes
ZA765684B (en) Novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
JPS5259119A (en) Preparation of trichloromethyll trifluoromethyllbenzene
IL50945A0 (en) Novel cephalosporins their preparation and pharmaceutical compositions containing them
JPS5273832A (en) Preparation of halogennitrobenzole
JPS56103173A (en) Novel dibenzopyrane intermediate and its manufacture
JPS5233692A (en) Novel cephlosporin
IL50150A0 (en) Preparation of 3-methoxymethyl-cephalosporins
IL50854A0 (en) Novel d-homosteroids their manufacture and pharmaceutical compositions containing them
GB1553664A (en) Antigenic compositions
JPS51135228A (en) Preparation of leaffmold